Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute. Learn more about Cancer Currents.
-
Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer MoonshotNCI’s new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.
-
The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.Dr. Greg Armstrong of the Childhood Cancer Survivor Study discusses this long-running study and its future.
-
Pancreatic Cancer Cells May Obtain Nutrients from Neighboring CellsPancreatic cancer cells instruct healthy cells around them to provide nutrients they need to survive and grow, a new study suggests.
-
Blue Ribbon Panel Report: The Power of the Cancer Community Coming TogetherNCI Acting Director Dr. Douglas R. Lowy, M.D., thanks the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.
-
Approach May Allow for Stem Cell Transplant without Radiation, ChemotherapyIn a recent study, researchers showed that a new approach may provide a safer way to perform stem cell transplants for treating cancer and other diseases.
-
Engineered Stem Cells Help Identify Potential New Treatment for MedulloblastomaStem cells engineered to mimic medulloblastoma development may help researchers identify potential new treatments, according to a new study.
-
Tumor DNA in Blood May Signal Response to T-Cell Transfer ImmunotherapyA study suggests that doctors could use circulating tumor DNA to quickly identify patients who are responding to T-cell transfer immunotherapy.
-
New on NCI’s Websites for August 2016An NCI Cancer Currents blog post that provides updates on new NCI websites and other online content of interest to the cancer community.
-
FDA Approves Pembrolizumab for Head and Neck CancerFDA granted pembrolizumab an accelerated approval for patients with recurrent or metastatic head and neck cancer that has continued to progress despite standard treatment with chemotherapy.
-
Nanoparticle that Mimics Salmonella Counteracts Chemotherapy ResistanceA nanoparticle that mimics Salmonella may help to counteract chemotherapy resistance, according to a new study.
-
CA-125 Testing, CT Scans Still Used for Ovarian Cancer Surveillance Despite Lack of Proven BenefitA new study shows clinicians continue to use CA-125 testing and CT scans to monitor for recurrences although the benefit of these tests has not been proven.
-
Adolescents Who Wouldn’t Have Smoked May Be Drawn to E-CigarettesThe findings from a recent study suggest that adolescents are not just using e-cigarettes as a substitute for conventional cigarettes but that e-cigarettes are attracting new users to tobacco products.
-
Mutations Linked to Immunotherapy ResistanceResearchers identified mutations in relapsed melanoma tumors that block the anticancer effects of the checkpoint inhibitor pembrolizumab.
-
Nanoparticle Delivers Cancer Drugs to Tumor Blood VesselsIn cancer mouse models, nanoparticles that bind to a protein called P-selectin on tumor blood vessels shrank tumors and extended survival.
-
Partner-Aided Skin Exams Increase Early Detection of New MelanomasPeople previously treated for melanoma can team up with a spouse, family member, or a friend and be trained to find new melanomas, a new study shows.
-
Inherited Mutations in DNA-Repair Genes Found in Advanced Prostate CancersResearchers estimate that nearly 12% of men with advanced prostate cancer have inherited mutations in genes that play a role in repairing damaged DNA.
-
Olanzapine Helps Prevent Nausea and Vomiting Caused by ChemotherapyA drug currently used to treat several psychiatric conditions can help prevent nausea and vomiting in patients receiving chemotherapy, a large clinical trial showed.
-
Anthrax Toxin-Based Cancer Therapy Targets Tumor Blood VesselsA therapy that uses the anthrax toxin selectively targets blood vessels that feed tumors and support their growth and spread, researchers have found.
-
New on NCI's Websites for July 2016An NCI Cancer Currents blog post that provides updates on new NCI websites and other online content of interest to the cancer community.
-
3-D View of Mutations May Identify Potential Targets for Cancer DrugsA new 3-D modeling tool may help identify mutations in cancer cells that could be targeted with new or existing drugs, a new study suggests.